Stock Caveat Emptor Status Changes Monday, October 7, 2013

Overview of iBio’s Fiscal Year 2024 Financial Results iBio, Inc. (NYSEA:IBIO), a leader in biopharmaceuticals using AI technology, has recently shared its financial performance for the fiscal year that ended on June 30, 2024. The company is dedicated to developing antibody therapies for complex conditions, utilizing machine learning approaches to enhance their efforts....

Exciting Developments for Atossa Therapeutics at Upcoming Symposium SEATTLE, November 2024 – Atossa Therapeutics, Inc. (NASDAQ: ATOS), a biopharmaceutical company known for its innovative approach in treating breast cancer, is gearing up to share groundbreaking research on (Z)-endoxifen at the upcoming San Antonio Breast Cancer Symposium (SABCS). This symposium is an...

Exciting Announcement for Sports Fans at Live! Casino & Hotel DraftKings is thrilled to announce its role as the official sportsbook for the highly anticipated Live! Casino & Hotel, which boasts a remarkable investment of over $270 million. This venue is set to create waves in the sports entertainment scene. The grand opening is expected, and it promises to be a game...

Transforming Learning Spaces with Collaborative Efforts In a remarkable initiative, School Specialty and the College Football Playoff Foundation are making strides in enhancing the educational landscape. Their recent accomplishment includes the makeover of a media center at North Dade Middle School, marking the 100th transformed learning environment as part of the Extra...

Velvet Taco Introduces New Velvet Bowls to Excite Diners In an exciting move to shake up its menu, Velvet Taco proudly announces the launch of its latest creation, the Velvet Bowls. This fresh offering arrives after a successful "Weekly Bowl Feature" campaign that highlighted the restaurant's adventurous flavors without the need for tortillas. As a taco restaurant renown...